[Homocamptothecins--novel promising anticancer drugs as inhibitors of topoisomerase I].
Yang
Song
S
School of Pharmacy, the Second Military Medical University, Shanghai 200433, China.
Zhang
Wan-nian
WN
D000818:Animals; D000970:Antineoplastic Agents / Q000138:chemical synthesis / Q000737:chemistry / Q000494:pharmacology; D000972:Antineoplastic Agents, Phytogenic / Q000138:chemical synthesis / Q000737:chemistry / Q000494:pharmacology; D002166:Camptothecin / Q000031:analogs & derivatives* / Q000138:chemical synthesis / Q000737:chemistry / Q000494:pharmacology; D004249:DNA Damage; D006801:Humans; D000077146:Irinotecan; D059004:Topoisomerase I Inhibitors; D019772:Topotecan / Q000138:chemical synthesis / Q000737:chemistry / Q000494:pharmacology; D014407:Tumor Cells, Cultured / Q000187:drug effects
D000970:Antineoplastic Agents; D000972:Antineoplastic Agents, Phytogenic; C121907:BN 80927; D059004:Topoisomerase I Inhibitors; D000077146:Irinotecan; D019772:Topotecan; C120029:homocamptothecin; D002166:Camptothecin